Inopak Ltd

Warning LetterOpen

United StatesFEI 1000122232Issued Feb 21, 2019

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 1000122232.

Letter Details

Firm: Inopak Ltd
Location: United States
FEI Number: 1000122232
Country: United States
Issue Date: February 21, 2019
Issuing Office: N/A
Product Type: Drugs
Status: Open

Summary

Based on limited metadata, Inopak Ltd, a drug manufacturer, received an FDA Warning Letter on February 21, 2019, indicating compliance issues with federal drug regulations. While the specific violations cannot be detailed without access to the full letter text, the warning falls under FDA's drug product oversight authority. The company was directed to address deficiencies in their manufacturing, quality control, or regulatory compliance procedures to meet current Good Manufacturing Practice (CGMP) standards or other applicable drug regulations.